ContraceptiveAdvantagesDisadvantages
Combined oral contraceptivesWidely available and affordableFailure rate for typical use is 8%; estrogen-containing contraceptives may increase blood levels of corticosteroids, cyclosporine (Sandimmune), tacrolimus (Prograf), and sirolimus
Intrauterine devicesNo increased risk of infection; no change in effectiveness for immunosuppressed patients; no drug interactions; does not contain estrogen
Intravaginal ring and combined hormonal contraceptive patchAvoids first-pass effect; may decrease risk of drug interactions with estrogen; intravaginal ring has lower total daily dose of estrogenComplications related to estrogen-containing contraceptives; increased circulating levels of estrogen with patch
Medroxyprogesterone (Provera)Avoids first-pass effect; does not contain estrogenU.S. Food and Drug Administration boxed warning for bone health combined with propensity for decreased bone mineral density
Subdermal implantsFewer bone density effects compared with medroxyprogesterone; does not contain estrogen